Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Mar 2025 – 20 Aug 2026, limited by ITI Bharat Consumption Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ITI Bharat Consumption Fund | Nifty 500 |
|---|---|---|
| 05 Mar 2025 | ₹100.00 | ₹100.00 |
| 18 Apr 2025 | ₹108.55 | ₹107.04 |
| 02 Jun 2025 | ₹110.92 | ₹112.73 |
| 16 Jul 2025 | ₹115.48 | ₹115.88 |
| 30 Aug 2025 | ₹115.75 | ₹110.89 |
| 13 Oct 2025 | ₹117.86 | ₹115.00 |
| 27 Nov 2025 | ₹118.78 | ₹118.22 |
| 10 Jan 2026 | ₹115.54 | ₹115.85 |
| 23 Feb 2026 | ₹107.91 | ₹115.94 |
| 09 Apr 2026 | ₹101.73 | ₹108.79 |
| 23 May 2026 | ₹105.36 | ₹111.82 |
| 07 Jul 2026 | ₹112.25 | ₹115.36 |
| 20 Aug 2026 | ₹116.65 | ₹116.08 |
| Metric | ITI · Direct · IDCW NAV ₹11.59 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| -1.24% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +11.13% | +11.82% | |
| +6.66% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 14.15% | 15.88% | |
| -0.55 | 0.35 | |
| -0.75 | 0.47 | |
| -20.86% | -25.18% | |
| Nifty 500 | — | |
| — | +1.40% | |
| — | 0.98 | |
| — | 101.5% | |
| — | 97.0% | |
| 0.96% | 1.14% | |
| ₹345.15Cr | ₹1,162Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 79% | 45% | |
| Rajesh Bhatia | — | |
| 05 Mar 2025 | — | |
| 54 | — | |
| 40.4% | — | |
| 1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.